Alert: Major Price Decline (3/22/24)-Fate Therapeutics Inc (NASDAQ: FATE).
Fate Therapeutics Inc (NASDAQ: FATE) stock closed at $6.61 on 3/22/24 after a major decline of -11.0%. However, below average trading volume at 68% of normal accompanied the decline. The stock has declined -8.6% during […]